Karthik Raman

Karthik Raman

Y Combinator Logo Batch: W23

Achievements

  • Karthik Raman is a Y Combinator W23 alum, one of the top startup programs
  • He holds a PhD in bioengineering with 9 patents in sustained-release tech
  • He helped push biotech automation at Zymergen, integrating robotics and AI
  • He co-founded Persist AI in 2022, disrupting drug formulation timelines from 5 to 2 years
  • Persist AI raised $16M in funding, including a $12M Series A led by Spero Ventures
  • His work is driving faster, cheaper, and more effective drug development in healthcare

Living for Karthik Raman

Time to appreciate Karthik Raman. This guy’s the real deal in biotech and startups. He’s a YC W23 alum, which already says a lot – only the best get into that batch. But what really makes him stand out is his process and what he’s building now.

Karthik’s background is deep in bioengineering, and he’s got nine patents in sustained-release tech – that’s some advanced stuff. Basically, he’s been tinkering with how drugs can be made to last longer inside your body, making treatments way more works well and less annoying for patients. Before he jumped into the startup world, he was grinding at big names like Zymergen, where he helped push automation in biotech – you know, making these crazy complex processes faster and smarter using robotics and AI.

And that’s kinda his vibe: pushing the boundaries of biotech with tech. He’s also worked at Bio-Rad Labs and was involved with Penumbra and Papyrus Bio, which are all about advanced biotech and automation. So, he’s no stranger to the industry’s nitty-gritty, and he’s been around the block in both big companies and startups.

Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.

Talk to her

Now, the big move? He co-founded Persist AI in 2022, and man, this company is changing the game. They’re using AI and robotics to speed up drug formulation from a 5-year slog to about 2 years. That’s huge. Imagine cutting down the time it takes to get life-saving meds to market – that’s what he’s all about. They’ve already raised $16 million, including a $12 million Series A led by Spero Ventures, with heavy hitters like Eli Lilly and Y Combinator in the mix. This isn’t some small project – this is the real deal, disrupting pharma as we know it.

What does all this say about him? Honestly, Karthik’s story is about relentless innovation and a deep drive to solve real-world problems. He’s not just in biotech to make a buck – he’s about making treatments faster, cheaper, better. His background shows he’s all about pushing technology to its limits, and he’s clearly got the vision and grit to turn those ideas into reality.

Bottom line? Karthik Raman is a biotech innovator on a mission. He’s blending his PhD hustle, patents, and industry experience to shake up how drugs are made, making a huge impact on healthcare. If you ask me, he’s the kind of founder who’s just getting started, and honestly, the world’s gonna feel that impact for years.

Founder ID: 102471

Share your thoughts about Karthik Raman

Have you worked with this founder? Know additional information? Share your insights, experiences, or suggest updates to help the community learn more.

Select your comment type:

Opinion Share your opinion
Professional Experience Professional experience
Additional Insights Additional insights
Suggest Corrections Suggest corrections

If something is wrong about Karthik Raman, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)

Your email address will not be published. Help us build a comprehensive founder database.